Jabodon PT Co’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Jabodon PT Co’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,716	Closed	-$2.99M	–	31
2019 Q4	$2.99M	Buy	21,716 +7,341	+51%	+$893K	1.14%	14
2019 Q3	$1.71M	Buy	14,375 +3,350	+30%	+$468K	0.72%	23
2019 Q2	$1.54M	Buy	11,025 +7,950	+259%	+$1.4M	1.2%	19
2019 Q1	$550K	Buy	+3,075	New	+$462K	0.46%	24

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Jabodon PT Co's ORTX Position: Q1 2020 in Review

Jabodon PT Co sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2020, closing a stake of 21,716 shares — an estimated $2.99M sold.

Jabodon PT Co first reported a position in ORTX in Q1 2019 and held it in 4 quarters. The position peaked at $2.99M in Q4 2019. 74 funds tracked by Wall St. Rank hold ORTX as of Q1 2020.

Jabodon PT Co reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Jabodon PT Co sold 21,716 Orchard Therapeutics plc American Depositary Shares shares in Q1 2020, an estimated $2.99M.
Jabodon PT Co first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 4 quarters.
Jabodon PT Co's Orchard Therapeutics plc American Depositary Shares position peaked at $2.99M in Q4 2019.
74 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2020.

Based on Jabodon PT Co's 13F filing for Q1 2020, filed 12 May 2020.